Analysis Metabolite Name Measured Value Units Group
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.5044Peak areaDiabetic non neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.5348Peak areaDiabetic Neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.5401Peak areaDiabetic non neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.5509Peak areaDiabetic non neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.5528Peak areaDiabetic Neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.5672Peak areaDiabetic Neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.5711Peak areaDiabetic non neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.6157Peak areaDiabetic non neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.6244Peak areaDiabetic non neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.6376Peak areaDiabetic Neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.6606Peak areaDiabetic Neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.6681Peak areaDiabetic Neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.6689Peak areaDiabetic non neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.6847Peak areaDiabetic Neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.6852Peak areaDiabetic non neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.6864Peak areaDiabetic non neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.7097Peak areaDiabetic Neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.7172Peak areaDiabetic Neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.7251Peak areaDiabetic Neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.7455Peak areaDiabetic non neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.7627Peak areaDiabetic non neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.7668Peak areaDiabetic non neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.7945Peak areaDiabetic Neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.8000Peak areaDiabetic non neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.8052Peak areaDiabetic non neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.8111Peak areaDiabetic non neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.8136Peak areaDiabetic Neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.8206Peak areaDiabetic Neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.8420Peak areaDiabetic non neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.8441Peak areaDiabetic Neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.8523Peak areaDiabetic Neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.8546Peak areaDiabetic non neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.8745Peak areaDiabetic Neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.8787Peak areaDiabetic non neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.8795Peak areaDiabetic Neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.8872Peak areaDiabetic Neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.8946Peak areaNormal
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.8982Peak areaDiabetic non neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.9073Peak areaDiabetic Neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.9109Peak areaDiabetic non neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.9202Peak areaDiabetic non neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.9255Peak areaDiabetic non neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.9297Peak areaDiabetic non neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.9315Peak areaDiabetic non neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.9399Peak areaDiabetic non neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.9521Peak areaDiabetic Neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.9602Peak areaDiabetic non neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.9697Peak areaDiabetic Neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.9863Peak areaDiabetic Neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.9884Peak areaDiabetic Neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.9937Peak areaDiabetic non neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.9984Peak areaDiabetic Neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)0.9991Peak areaNormal
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.0009Peak areaDiabetic Neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.0042Peak areaDiabetic Neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.0046Peak areaDiabetic non neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.0147Peak areaDiabetic non neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.0192Peak areaNormal
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.0207Peak areaDiabetic Neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.0271Peak areaDiabetic non neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.0280Peak areaDiabetic Neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.0363Peak areaDiabetic Neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.0528Peak areaDiabetic Neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.0799Peak areaDiabetic Neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.0906Peak areaDiabetic Neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.0958Peak areaDiabetic non neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.1250Peak areaNormal
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.1258Peak areaNormal
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.1261Peak areaDiabetic Neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.1322Peak areaDiabetic Neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.1335Peak areaDiabetic non neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.1392Peak areaDiabetic non neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.1455Peak areaDiabetic non neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.2035Peak areaDiabetic Neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.2121Peak areaDiabetic non neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.2274Peak areaDiabetic Neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.2420Peak areaDiabetic non neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.2547Peak areaDiabetic Neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.2555Peak areaNormal
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.2597Peak areaDiabetic Neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.2738Peak areaDiabetic non neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.2749Peak areaDiabetic non neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.2949Peak areaDiabetic Neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.2978Peak areaDiabetic non neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.3479Peak areaDiabetic Neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.3907Peak areaDiabetic Neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.4114Peak areaDiabetic non neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.4419Peak areaNormal
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.4479Peak areaDiabetic Neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.4776Peak areaDiabetic non neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.4779Peak areaNormal
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.5150Peak areaDiabetic non neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.5349Peak areaDiabetic non neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.5369Peak areaDiabetic non neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.5447Peak areaDiabetic Neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.5923Peak areaDiabetic non neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.6293Peak areaDiabetic non neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.7001Peak areaNormal
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.7379Peak areaDiabetic Neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.7915Peak areaDiabetic Neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.8653Peak areaDiabetic non neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.9246Peak areaDiabetic Neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)1.9979Peak areaDiabetic Neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)2.3828Peak areaDiabetic non neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)2.3958Peak areaDiabetic non neuropathy
HILIC POSITIVE ION MODE1-palmitoyl-GPE (16:0)3.0120Peak areaDiabetic Neuropathy

Return to search page
  logo